The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

West Pharmaceutical (NYSE:WST) surges after Q2 results beat estimates & full-year guidance rises. Read more here.

GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.